Research ArticleHIV

A live-attenuated RhCMV/SIV vaccine shows long-term efficacy against heterologous SIV challenge

See allHide authors and affiliations

Science Translational Medicine  17 Jul 2019:
Vol. 11, Issue 501, eaaw2607
DOI: 10.1126/scitranslmed.aaw2607

Article Information

vol. 11 no. 501

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication December 3, 2018
  • Resubmitted March 14, 2019
  • Accepted for publication June 13, 2019
  • .

Author Information

  1. Scott G. Hansen1,
  2. Emily E. Marshall1,*,
  3. Daniel Malouli1,
  4. Abigail B. Ventura1,
  5. Colette M. Hughes1,
  6. Emily Ainslie1,
  7. Julia C. Ford1,
  8. David Morrow1,
  9. Roxanne M. Gilbride1,
  10. Jin Y. Bae1,
  11. Alfred W. Legasse1,
  12. Kelli Oswald2,
  13. Rebecca Shoemaker2,
  14. Brian Berkemeier2,
  15. William J. Bosche2,
  16. Michael Hull2,
  17. Jennie Womack1,
  18. Jason Shao3,
  19. Paul T. Edlefsen3,
  20. Jason S. Reed1,
  21. Ben J. Burwitz1,
  22. Jonah B. Sacha1,
  23. Michael K. Axthelm1,
  24. Klaus Früh1,
  25. Jeffrey D. Lifson2 and
  26. Louis J. Picker1,
  1. 1Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
  2. 2AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.
  3. 3Statistical Center for HIV/AIDS Research and Prevention, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
  1. Corresponding author. Email: pickerl{at}ohsu.edu
  • * Present address: Vir Biotechnology, 4640 SW Macadam Avenue, Portland, OR 97239, USA.

Altmetric

Article usage

Article usage: July 2019 to August 2020

AbstractFullPdf
Jul 20192922712298
Aug 20192489296
Sep 20191266059
Oct 2019904861
Nov 2019885038
Dec 20191094137
Jan 2020844134
Feb 2020733021
Mar 2020752918
Apr 20202503120
May 20201461314
Jun 202070139
Jul 202031228
Aug 202021411

Stay Connected to Science Translational Medicine

Navigate This Article